| abstract |
The present invention treats vascular conditions (eg, atherosclerosis, or hypercholesterolemia), diabetes, obesity, stroke, demyelination and lowers sterol and / or stanol plasma levels in a subject. Provided are substituted azetidinone compounds of formula (I), formulations and methods of preparing the formulations that may be useful. Compounds of formula (I) can be metabolized in vivo to form sterol absorption inhibitor compounds and / or stanol absorption inhibitor compounds and sterol biosynthesis inhibitor compounds. Embedded image |